To the content
1 . 2021

Violation of vaginal microbiocenosis and ways of its correction: interaction of science and practice

Abstract

The review presents a meta-analysis of current clinical studies on the role of the vaginal microbiome in the diagnosis and treatment of urogenital infections. Relevant ideas about the identification of various pathogens associated with bacterial vaginosis (BV), the possibilities of its diagnosis and prevention are highlighted. In particular, the effectiveness of existing BV treatment methods is assessed in terms of achieving a clinical effect, the presence of long-term side effects and the possibility of a relapse of the disease. The method of BV treatment with probiotic preparations containing lactobacilli was analyzed from the same point of view. At the same time, science does not stand still, and with the advent and implementation of new modern diagnostic methods, the concept of a number of diseases of the lower part of the urogenital tract, such as bacterial vaginosis, aerobic vaginitis, vulvovaginal candidiasis and infections, is changing urinary tract.

Keywords:bacterial vaginosis, vaginal microbiocenosis, lactobacilli, probiotics

Funding. The authors received no financial support.

Conflict of interests. The authors declare no conflict of interests.

For citation: Bayramova G.R., Andreev А.О., Dobrovolskaya D.A., Peremykina A.V. Violation of vaginal microbiocenosis and ways of its correction: interaction of science and practice. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2021; 9 (1): 44-51. DOI: https://doi.org/10.33029/2303-9698-2021-9-1-44-51 (in Russian)

References

1. Hobday A.J., Haury L., Dayton P.K. Function of the human hymen. Med Hypotheses. 1997; 49 (2): 171-3.

2. Al-Achi A. An Introduction to Botanical Medicines: History, Science, Uses, and Dangers. Westport, CT: Praeger Publishers, 2008: 126 p.

3. van Leeuwenhoek A. Microscopical observations concerning blood, milk, bone, the brain, spittle, and cuticula. Philos Trans (London). 1674; 9: 121-8.

4. Reid G., Younes J.A., Van der Mei H.C., Gloor G.B., Knight R., Buss-cher H.J. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol. 2011; 9 (1): 27-38.

5. Hummelen R., Fernandes A.D., Macklaim J.M., et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One. 2010; 5 (8): e12078.

6. Zhou X., Westman R., Hickey R., et al. Vaginal microbiota of women with frequent vulvovaginal candidiasis. Infect Immun. 2009; 77 (9): 4130-5.

7. Siddiqui H., Nederbragt A.J., Lagesen K., Jeansson S.L., Jakob-sen K.S. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol. 2011; 11: 244.

8. Ravel J., Gajer P., Abdo Z., et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011; 108 (suppl 1): 4680-7.

9. Brown J.M., Hess K.L., Brown S., Murphy C., Waldman A.L., He-zareh M. Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States. Obstet Gynecol. 2013; 121 (4): 773-80.

10. Ferris D.G., Nyirjesy P., Sobel J.D., Soper D., Pavletic A., Litaker M.S. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol. 2002; 99 (3): 419-25.

11. Shipitsyna E., Roos A., Datcu R., et al. Composition of the vaginal microbiota in women of reproductive age - sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS One. 2013; 8 (4): e60670.

12. Gardner H.L., Dukes C.D. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955; 69 (5): 962-76.

13. Holmes K.K., Spiegel C., Amsel A.R., Eschenbach D.A., Chen K.C., Totten P. Nonspecific vaginosis. Scand J Infect Dis Suppl. 1981; 26: 110-4.

14. Greaves W.L., Chungafung J., Morris B., Haile A., Townsend J.L. Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol. 1988; 72 (5): 799-802.

15. Koren O., Knights D., Gonzalez A., et al. A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput Biol. 2013; 9 (1): e1002863.

16. Fernandes A.D., Macklaim J.M., Linn T.G., Reid G., Gloor G.B. ANOVA-like differential expression (ALDEx) analysis for mixed population RNA-Seq. PLoS One. 2013; 8 (7): e67019.

17. O'Dowd T.C., Parker S., Kelly A. Women's experiences of general practitioner management of their vaginal symptoms. Br J Gen Pract. 1996; 46 (408): 415-8.

18. Johnson S.R., Griffiths H., Humberstone F.J. Attitudes and experience of women to common vaginal infections. J Low Genit Tract Dis. 2010; 14 (4): 287-94.

19. Payne S.C., Cromer P.R., Stanek M.K., Palmer A.A. Evidence of African-American women's frustrations with chronic recurrent bacterial vaginosis. J Am Acad Nurse Pract. 2010; 22 (2): 101-8.

20. Reid G., Zorzitto M.L., Bruce A.W., Jewett M.A.S., Chan R.C.Y., Costerton J.W. The pathogenesis of urinary tract infection in the elderly: the role of bacterial adherence to uroepithelial cells. Curr Microbiol. 1984; 11 (2): 67-72.

21. Kirjavainen P., Pautler S., Baroja M.L., et al. Aberrant vaginal microbiota and IL-12 skewed cytokine production by antigen-presenting cells are characteristic of women prone to urinary tract infections. Clin Vaccine Immunol. 2008; 16 (1): 29-36.

22. Davis C.P., Cohen M.S., Anderson M.D., Gruber M.B., Warren M.M. Urothelial hyperplasia and neoplasia. II. Detection of nitrosamines and interferon in chronic urinary tract infections in rats. J Urol. 1985; 134 (5): 1002-6.

23. Nordenstam G.R., Brandberg C.A., Oden A.S., Svanborg Eden C.M., Svanborg A. Bacteriuria and mortality in an elderly population. N Engl J Med. 1986; 314 (18): 1152-6.

24. Williams D.H., Schaeffer A.J. Current concepts in urinary tract infections. Minerva Urol Nefrol. 2004; 56 (1): 15-31.

25. Wagenlehner F.M., Hoyme U., Kaase M., FunfstCick R., Naber K.G., Schmiemann G. Uncomplicated urinary tract infections. Dtsch Arztebl Int. 2011; 108 (24): 415-23.

26. Raz R. Fosfomycin: an old - new antibiotic. Clin Microbiol Infect. 2012; 18 (1): 4-7.

27. Madani Y., Mann B. Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections. Prim Care Respir J. 2012; 21 (3): 337-41.

28. Ferry S.A., Holm S.E., Stenlund H., Lundholm R., Monsen T.J. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Health Care. 2007; 25 (1): 49-57.

29. Kim T.K., Thomas S.M., Ho M., et al. Heterogeneity of vaginal microbial communities within individuals. J Clin Microbiol. 2009; 47 (4): 1181-9.

30. Hickey R.J., Zhou X., Pierson J.D., Ravel J., Forney L.J. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res. 2012; 160 (4): 267-82.

31. Menard J.P., Mazouni C., Fenollar F., Raoult D., Boubli L., Bretelle F. Diagnostic accuracy of quantitative real-time PCR assay versus clinical and Gram stain identification of bacterial vaginosis. Eur J Clin Microbiol Infect Dis. 2010; 29 (12): 1547-52.

32. Macklaim J.M., Cohen C.R., Donders G., et al. Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease. Reprod Sci. 2012; 19 (11): 1154-62.

33. Hall-Stoodley L., Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009; 11 (7): 1034-43.

34. Conrad D., Haynes M., Salamon P., Rainey P.B., Youle M., Rohwer F. Cystic fibrosis therapy: a community ecology perspective. Am J Respir Cell Mol Biol. 2013; 48 (2): 150-6.

35. Qin Z., Yang L., Qu D., Molin S., Tolker-Nielsen T. Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiology. 2009; 155 (pt 7): 2148-56.

36. McMillan A., Dell M., Zellar M.P., et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011; 86 (1): 58-64.

37. Absolom D.R. The role of bacterial hydrophobicity in infection: bacterial adhesion and phagocytic ingestion. Can J Microbiol. 1988; 34 (3): 287-98.

38. Verstraelen H., Swidsinski A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Curr Opin Infect Dis. 2013; 26 (1): 86-9.

39. Macklaim J.M., Fernandes A.D., Reid G., Gloor G.B. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome. 2013; 1: 12.

40. Nicholson J.K., Holmes E., Kinross J.M., Darzi A.W., Takats Z., Lindon J.C. Metabolic phenotyping in clinical and surgical environments. Nature. 2012; 491 (7424): 384-92.

41. Luong M.L., Libman M., Dahhou M., et al. Vaginal douching, bacterial vaginosis, and spontaneous preterm birth. J Obstet Gynaecol Can. 2010; 32 (4): 313-20.

42. Enos M., Burton J.P., Dols J., et al. Probiotics and nutrients for the first 1000 days of life in the developing world. Benef Microbes. 2013; 4 (1): 3-16.

43. Reid G., Charbonneau D., Erb J., et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003; 35 (2): 131-4.

44. Beerepoot M.A., ter Riet G., Nys S., et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012; 172 (9): 704-12.

45. Morelli L., Zonenenschain D., Del Piano M., Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol. 2004; 38 (6 suppl): S107-10.

46. Reid G., Bruce A.W. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis. 2001; 183 (suppl 1): S77-80.

47. FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group. 2002.

48. Nazarenko L. G., Solovieva N. P. Oral probiotic use as an alternative clinical strategy for the prevention of obstetric and perinatal infections. Zdorov'e zhenshchiny [Woman's Health]. 2013; 6 (82): 91-6. (in Russian)

49. Shikh E.V. New aspects in the treatment of vaginal dysbiosis. Меdvestniк [Electronic resource]. VGC-17.07.2020. URL: https://med-vestnik.ru/content/interviews/Novye-aspekty-v-lechenii-vaginalnyh-dis-biozov.html (in Russian)

50. Reid G., Burton J., Hammond J.A., Bruce A.W. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J Med Food. 2004; 7 (2): 223-8.

51. Petricevic L., Unger F.M., Viernstein H., Kiss H. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2008; 141: 54-7.

52. Anukam K.S., Osazuwa E., Osemene G.I., et al. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 2006; 8 (12-13): 2772-6.

53. Martinez R.C., Franceschini S.A., Patta M.C., Quintana S.M., Gomes B.C., De Martinis E.C., et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol. 2009; 55 (2):133-8.

54. Martinez R.C., Franceschini S.A., Patta M.C., Quintana S.M., Can-dido R.C., Ferreira J.C., et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol. 2009; 48: 269-74.

55. Krauss-Silva L., Moreira M., Alves M., Braga A. A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results. Trials. 2011; 12 (1): 239. DOI: https://doi.org/10.1186/1745-6215-12-239

56. Ho M., Chang Y.-Y., Chang W.-C., et al. Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: a randomized controlled trial. Taiwan J Obstet Gynecol. 2016; 55 (4): 515-8.

57. Kairys N., Garg M. Bacterial Vaginosis. Treasure Island, FL: Stat-Pearls Publishing, 2021.

58. Jain J.P., Bristow C.C., Pines H.A., Harvey-Vera A., Rangel G., Staines H., et al. Factors in the HIV risk environment associated with bacterial vaginosis among HIV-negative female sex workers who inject drugs in the Mexico-United States border region. BMC Public Health. 2018; 18 (1): 1032.

59. Han C., Li H., Han L., Wang C., Yan Y., Qi W., et al. Aerobic vaginitis in late pregnancy and outcomes of pregnancy. Eur J Clin Microbiol Infect Dis. 2019; 38 (2): 233-9.

60. Redelinghuys M.J., Geldenhuys J., Jung H., Kock M.M. Bacterial vaginosis: current diagnostic avenues and future opportunities. Front Cell Infect Microbiol. 2020; 10: 354. DOI: https://doi.org/10.3389/fcimb.2020.00354 PMID: 32850469; PMCID: PMC7431474.

61. Deese J., Masson L., Miller W., Cohen M., Morrison C., Wang M., et al. Injectable progestin-only contraception is associated with increased levels of pro-inflammatory cytokines in the female genital tract. Am J Reprod Immunol. 2015; 74: 357-67. DOI: https://doi.org/10.1111/aji.12415

62. Bayramova G.R., Amirkhanyan A.S., Chernova V.F. Vulvovaginal candidiasis: pathogenesis, diagnosis and treatment Strategy. Doctor.Ru. 2018; 10 (154): 32-6. DOI: https://doi.org/10.31550/1727-2378-2018-154-10-32-36 (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITORS
CHIEF EDITOR
Sukhikh Gennadii Tikhonovich
Academician of the Russian Academy of Medical Sciences, V.I. Kulakov Obstetrics, Gynecology and Perinatology National Medical Research Center of Ministry of Healthсаre of the Russian Federation, Moscow
CHIEF EDITOR
Kurtser Mark Arkadievich
Academician of the Russian Academy of Sciences, MD, Professor, Head of the Obstetrics and Gynecology Subdepartment of the Pediatric Department, N.I. Pirogov Russian National Scientific Research Medical University, Ministry of Health of the Russian Federation
CHIEF EDITOR
Radzinsky Viktor Evseevich
Corresponding Member of the Russian Academy of Sciences, MD, Professor, Head of the Subdepartment of Obstetrics and Gynecology with a Course of Perinatology of the Medical Department in the Russian People?s Friendship University

Journals of «GEOTAR-Media»